MK
Insider selling
Mark Kaye sold $4.7M of ELV stock
Mark Kaye, EVP & CFO of Elevance Health, Inc. (ELV), sold 10,584 shares of ELV stock worth $4.7M, per an SEC Form 4 filed Oct 23, 2026.
It was an open-market sale.
The trade happened on Oct 22, 2026, 1 day before it was made public.
ELV has moved -1.2% since the trade date, from $445.28 to $439.95 (Oct 23, 2026 close).
- Traded
- Oct 22, 2026
- Disclosed
- Oct 23, 2026
- Filing delay
- 1 day
- Price since
- -1.2%
- Role
- EVP & CFO
- Source
- SEC Form 4
More ELV insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.